[144] CALIX, INC. SEC Filing
Calix, Inc. (CALX) notice reports a proposed sale under Rule 144 of 18,010 common shares valued at $1,134,630 to be sold through Morgan Stanley Smith Barney on the NYSE on 09/11/2025. The filing shows these 18,010 shares were acquired the same day by stock option exercise from the issuer and paid in cash. The form also discloses multiple recent sales by Michael Weening totaling 581,990 shares sold across six transactions between 07/22/2025 and 09/10/2025 with gross proceeds shown per transaction. The filing does not provide the issuer address or additional narrative disclosures.
- None.
- None.
Insights
TL;DR: Insider intends to sell newly exercised shares and has been an active seller in recent months, generating material proceeds.
The notice documents a proposed Rule 144 sale of 18,010 shares acquired by option exercise and paid in cash, to be executed via Morgan Stanley on the NYSE on 09/11/2025. The schedule of prior sales by Michael Weening shows substantial dispositions totaling 581,990 shares across six trades from 07/22/2025 to 09/10/2025 with aggregate proceeds reported per trade. For investors, this is a clear record of insider liquidity events; the filing contains no forward-looking commentary or issuer-specific operational data.
TL;DR: Routine compliance filing documenting an insider sale tied to option exercise; no governance red flags disclosed here.
The submission follows Rule 144 requirements by identifying class, broker, sale date, acquisition method, and payment type. It confirms the seller's representation about material nonpublic information but provides no additional context on any trading plan or 10b5-1 adoption date. The form lacks issuer contact details and explicit signature block content within the provided text, limiting assessment to transaction-level disclosure only.